. 2022 Oct 1;26(10):762–770. doi: 10.5152/AnatolJCardiol.2022.1787
Content of this journal is licensed under a Table 2.
Demographic and Biochemical Characteristics of the Group with And Without Hepatosteatosis
| Non-Hepatosteatosis Group (n = 154) | Hepatosteatosis Group (n = 182) | P | |
|---|---|---|---|
| Age | 43.6 ± 11.16 | 56.25 ± 10.74 | <.001 |
| Gender (F/M) | 73/80 | 35/48 | .258 |
| Total cholesterol (mg/dL) | 201.12 ± 45.51 | 200.75 ± 47.27 | .960 |
| HDL cholesterol (mg/dL) | 45.96 ± 11.97 | 44.11 ± 11.23 | .328 |
| LDL cholesterol (mg/dL) | 123 (52.75) | 121.5 (40.33) | .565 |
| Triglyceride (mg/dL) | 135.5 (100.75) | 145.5 (99) | .516 |
| BMI (kg/m2) | 25.93 ± 2.96 | 30.62 ± 5.03 | <.001 |
| HT (mm Hg) | 61 (39.8%) | 61 (73.4%) | <.001 |
| CVD | 5 (3.2%) | 46 (55.4%) | <.001 |
| CVD family history | 57 (37.2%) | 50 (60.2%) | .001 |
| Liver attenuation (HU) | 62.05 ± 6.15 | 50.32 ± 7.93 | <.001 |
| L/S ratio | 1.32 ± 0.9 | 1.01 ± 0.13 | <.001 |
| EAT volume (mm3) | 69.03 (30.95) | 112.24 (44) | <.001 |
HDL, high-density lipoprotein; LDL, low-density lipoprotein; BMI, body mass index; HT, hypertension; CVD, cardiovascular disease; L/S, liver–spleen ratio; EAT volume, epicardial adipose tissue volume.